Federal award (DEFINITIVE CONTRACT, fiscal year 2024)
Recipient: CFD RESEARCH CORPORATION
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2023-05-19 to 2026-05-18
Current total value of award: $1099949.64
Description: THIS SMALL BUSINESS INNOVATION RESEARCH PHASE II IS FOR DEVELOPMENT OF A NEW BROAD-SPECTRUM ANTIVIRAL DRUG AGAINST VIRUSES FROM THE BUNYAVIRAL